Previous 10 | Next 10 |
InMode to Present at the 23rd Annual Needham Growth Conference PR Newswire YOKNEAM, Israel , Jan. 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy , C...
InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...
Oasis Treatment Tent by La Belle Vie MedSpa featuring InMode Premier California Medical Spa Offers COVID-Friendly Outdoor Luxury Experience with InMode Treatments PR Newswire WOODLAND HILLS, Calif., Nov. 16, 2020 WOODLAND HILLS, Calif. , Nov. 16, 2020 /PR...
InMode has seen a tough first and second quarter for obvious reasons, yet remained incredibly profitable. Net cash balances never put the viability of the company in doubt as valuations were far too low in the spring. Shares have seen a big recovery, although more than fully backe...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q3 2020 Earnings Call Nov 12, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q3 2020 Earnings Call Transcript
InMode Ltd. (INMD) Q3 2020 Earnings Conference Call November 12, 2020 08:30 ET Company Participants Miri Segal - MS, IR Moshe Mizrahy - CEO & Chairman Shakil Lakhani - President of InMode, North America Yair Malca - CFO Spero Theodorou - Chief Medical Officer Conference Call Participants ...
InMode (INMD): Q3 Non-GAAP EPS of $0.63 beats by $0.15; GAAP EPS of $0.57 beats by $0.17.Revenue of $59.71M (+49.2% Y/Y) beats by $7.09M.Press Release For further details see: InMode EPS beats by $0.15, beats on revenue
InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63 PR Newswire YOKNEAM, Israel, Nov. 12, 2020 YOKNEAM, Israel, Nov. 12...
[[BAM]], [[DAVA]], [[ENR]], [[EPC]], [[GDRX]], [[HIMX]], [[IGT]], [[INMD]], [[MTOR]], [[NICE]], [[NVMI]], [[PDD]], [[SBH]], [[SDGR]], [[SFL]], [[SSRM]], [[SSYS]], [[TDG]], [[TGP]], [[TNK]], [[TUFN]], [[WIX]]For Seeking Alpha's full earnings season calendar, click here. For further details s...
InMode (NASDAQ:INMD) is scheduled to announce Q3 earnings results on Thursday, November 12th, before market open.The consensus EPS Estimate is $0.48 (+14.3% Y/Y) and the consensus Revenue Estimate is $52.62M (+31.5% Y/Y).Over the last 1 year, INMD has beaten EPS estimates 75% of the time and ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...